OwlTail

Cover image of Rick Doblin

Rick Doblin

67 Podcast Episodes

Latest 25 Jan 2022 | Updated Daily

Weekly hand curated podcast episodes for learning

Episode artwork

Ep. 3 – Legalizing Psychedelics with Rick Doblin

Set and Setting with Madison Margolin

MAPS founder, Rick Doblin, joins Madison to talk psychedelic legalization, MDMA assisted psychotherapy, and to dive into his personal spiritual experiences and practices.This podcast is brought to you by BetterHelp. Click to receive 10% off your first month with your own licensed professional therapist: betterhelp.com/beherenowRick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, writing his dissertation on the regulation of the medical uses of psychedelics and marijuana. His undergraduate thesis at New College of Florida was a 25-year follow-up to (Ram Dass' and Tim Leary's) classic Good Friday Experiment. Rick studied with Dr. Stanislav Grof, and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana. He currently resides in Boston with his wife, dog, and empty rooms from three children.For more on Rick Doblin's psychedelic research, visit MAPS.org. To learn about Madison Margolin, head over to MadisonMargolin.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

52mins

10 Jan 2022

Episode artwork

MDMA-Assisted Therapy for PTSD with Rick Doblin, PhD

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

In this episode of the Psychedelic Medicine Podcast (formerly the Plant Medicine Podcast), Rick Doblin joins to discuss the past, present, and future of MDMA-assisted therapy. Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies. He received his doctorate in public policy from Harvard and has also studied under the father of transpersonal psychology Stanislav Grof. Through MAPS, Rick aspires to develop legal contexts for beneficial uses of psychedelics and marijuana as prescription medicines, but also for self-development and personal growth in otherwise healthy individuals. Rick begins this wide-ranging conversation discussing the early days of MDMA. The compound was originally synthesized by famed chemist Alexander "Sasha" Shulgin and, unlike the classic serotonergic psychedelics, it was not scheduled under the Controlled Substances Act in the early 70s. It was during this period of legality that therapeutic uses of MDMA were first developed and it was only later that the drug became repurposed as a recreational substance to be used in social settings, which consequently led to its emergency scheduling by the DEA. Rick recalls his own initial experiences with the empathogenic compound, stating that he was initially skeptical of its value, prior to gaining first-hand experience. Following this experience, however, he became convinced of its therapeutic potential and he shares some of his own early experiences of using MDMA to help people heal, including a very touching tale of his own grandmother’s struggle with depression. From here, Rick discusses the founding of MAPS and his decision to pursue education in policy in order to better understand strategies for furthering MDMA-therapy even while living under prohibition. Since that time, MAPS has gone on to do incredibly impactful work in developing studies researching the safety and efficacy of MDMA-assisted therapy, specifically for post-traumatic stress disorder. Rick shares the progression of these studies, highlighting the results from the most recent phase three investigations which are the last step prior to FDA approval for the therapeutic protocol. These studies show high statistical significance and an amazing effect size resulting from MDMA-assisted therapy, with results being mirrored at all research locations and showing durability over time.  Because of this amazing progress, Rick believes we are at the final stretch prior to full FDA approval for MDMA use in a therapeutic context for PTSD, and subsequent rescheduling of the substance by the DEA, which he believes will take place in mid to late 2023. This development will have broad global impacts, spurring other countries to promptly follow suit. Rick closes out this discussion by emphasizing the need for mass mental health in our day and age, and sharing MAPS’ lofty goals of training thousands of therapists to hopefully bring psychedelic therapy to millions of patients in the coming decades.  In this episode: Rick Doblin’s personal journey The history of the MDMA’s synthesis and legality Rick’s first experiences with MDMA and early experiments with MDMA therapy MAPS’ “two-pronged” strategy for mass mental health Early efforts to get an MDMA therapy protocol approved by the FDA following prohibition The politics of concerns about MDMA neurotoxicity and how this impacted MAPS’ early approach The results of the first phase three studies of MDMA for PTSD How FDA approval of MDMA will lead to an international cascade of approval and rescheduling Rick’s predictions for psychedelic medicine in the years to come  Quotes: “What a lot of people don’t know is that MDMA was a therapy drug before it was a party drug. And it was the party drug nature of it that really got it criminalized.” [7:38] “Seeing what it was like when it was legal and experiencing that, and experiencing situations where people would take it, the kind of experiences and healings, and learnings that people would have, was amazing.” [19:12] “What we need is, I believe, legal access to medicinal MDMA, covered by insurance, by trained professionals, and psychedelic clinics. And we also need a whole different kind of drug policy for non-medical use that involves honest drug education, access to pure substances, harm reduction, peer support, and also treatment on demand.” [21:08] “The irony here is that the first legal move against MDMA was illegal. The DEA did not have the authority to emergency schedule drugs.” [23:43] “FDA is legally bound to approve MDMA for PTSD if these [phase 3] studies generate statistically significant evidence of efficacy, and there are no new safety problems.” [40:27] “We think by the third quarter of 2023 we will have FDA approval assuming the second phase 3 study goes well. And then by the fourth quarter, the DEA has to reschedule [MDMA].” [51:18] “What’s even greater is the 12-month follow-up data was 67% no longer had PTSD. So people kept getting better—not only was it durable, but they kept getting better.” [55:00] “The thing to emphasize here is that MDMA is not the treatment. The treatment is therapy. The MDMA makes the therapy more effective and there can be different kinds of therapy that are used with it.” [1:01:38] Links: MAPS website Rick Doblin on Twitter Trip of Compassion Documentary The Way of the Psychonaut Books by Stanislav Grof Upcoming MAPS Psychedelic Science Conference 2023 Becoming an MDMA-Assisted Therapist with Shannon Carlin, MA, LMFT Psychedelic Medicine Association Porangui

1hr 18mins

5 Jan 2022

Similar People

Episode artwork

Rick Doblin, Founder and Executive Director of MAPS

Green Rush Podcast

This week on the Green Rush, we’re reaching way back into the vault to revisit Lewis Goldberg and Anne Donohoe first interviewed Rick Doblin, Founder and Executive Director of MAPS. Founded by Rick in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.  In this episode, Lewis and Anne spoke with Rick about the FDA regulated MDMA trials being run by MAPS as well as some of the ways Rick was keeping himself occupied and focused at the beginning of the COVID-19 pandemic. Over the decades, Rick Doblin has established himself as a leading authority on the renaissance of psychedelics and his insights on how these molecules may be able to solve the global mental health crisis will not be something that you want to miss. So sit back, relax and listen to our special fireside chat with Rick Doblin. Links and mentions in the show MAPS website: https://maps.org/ Rick Doblin’s TED Talks: https://www.ted.com/speakers/rick_doblin Links to the guest’s company and social media accounts Rick Doblin’s Twitter: https://twitter.com/rickdoblin MAPS Twitter: https://twitter.com/MAPS Rick Doblin’s LinkedIn: https://www.linkedin.com/in/rickdoblin/ MAPS Instagram: https://www.instagram.com/mapsnews/ Show Credits:This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther.You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter: @The_GreenRush Instagram: @thegreenrush_podcastLinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/ YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

1hr 17mins

18 Nov 2021

Episode artwork

#322 The MDMA Therapy Revolution With Rick Doblin

Aubrey Marcus Podcast

Rick Doblin is the founder of MAPS and has been pioneering psychedelic research for decades. He joins me to talk about the promising results MDMA assisted psychotherapy has shown in treating PTSD, a problem that has plagued humanity for eons. He addresses the current state of the clinical studies, and all of the intricacies that come with getting it approved as a medicine. As legalization is on the horizon, it brings revolutionary potential to heal the hearts and minds of even the most severely traumatized among us--ushering in a new era of mental health.  Connect with MAPS Website | https://maps.org/ Instagram | https://www.instagram.com/mapsnews/ Facebook | https://www.facebook.com/mapsmdma YouTube | https://www.youtube.com/user/mapsmdma Twitter | https://twitter.com/maps This episode is sponsored by: JUSTWORKS Find out how Justworks can help your business by visiting https://justworks.com/ Go to eightsleep.com/AMP to check out the Pod Pro and save $150 at checkout using Promo Code: AMP Black Swan Yoga Check out BSY.TV and use the code word "Aubrey" at checkout to get 1 free month of FREE online yoga Onnit Get 10% off Onnit products |  https://www.onnit.com/Aubrey/ Connect with Aubrey: Website | https://www.aubreymarcus.com/ Instagram | https://www.instagram.com/aubreymarcus/ Twitter | https://twitter.com/aubreymarcus Facebook | https://www.facebook.com/AubreyMarcus/ YouTube | https://bit.ly/2DLctpk Check out  Own The Day Own Your Life by Aubrey Marcus|  https://bit.ly/2t6x4hu Subscribe to the Aubrey Marcus Newsletter:  https://www.aubreymarcus.com/pages/email Subscribe to the Aubrey Marcus Podcast: iTunes | https://apple.co/2lMZRCn Spotify | https://spoti.fi/2EaELZO Stitcher | https://bit.ly/2G8ccJt IHeartRadio | https://ihr.fm/397Msh0 Google Podcasts | https://bit.ly/3nzCJEh Android | https://bit.ly/2OQeBQg Past Guests on The Aubrey Marcus Podcast include Joe Rogan, Jordan Peterson, Joe Dispenza, Andrew Huberman, Matthew McConaughey, Peter Crone, Jamie Foxx, Zach Bush, Duncan Trussell, Sadhguru, and many more!

2hr 5mins

18 Aug 2021

Most Popular

Episode artwork

Episode 57 - Rick Doblin

Comes A Time

In this episode of Comes a Time, psychedelic researcher and drug activist Rick Doblin joins Oteil and Mike for an informative conversation about psychedelics, wolves, and cultural progress. During the introduction, Oteil says “I’m telling you, watch this one” and he sure wasn’t kidding! This is a can’t-miss conversation, and Rick delivers new insights on some of our favorite frequently-visited topics on Comes a Time. You’ll hear the three talk in-depth about psychedelics and unexpectedly positive political developments regarding psychedelic treatment, and a vivid dream that Rick had which solidified his confidence in his life’s mission. They also discuss Rick’s pet wolf that he raised from a pup, a mystical experience that Rick had on MDMA where he felt universal love as he was “cradled in the arms of gravity,” and much more.  Rick Doblin, Ph.D., is a psychedelic researcher and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He founded the nonprofit research and educational organization in 1986, which works to raise awareness and understanding of psychedelic substances. Rick received his doctorate in Public Policy from Harvard's Kennedy School of Government, and has conducted numerous impactful psychedelic experiments including a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick aims to help develop legal contexts for the beneficial uses of psychedelics and marijuana, and to eventually become a legally licensed psychedelic therapist.*DISCLAIMER: This podcast does NOT provide medical advice. The information contained in this podcast is for informational and entertainment purposes only. No material in this podcast is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen*-----------This podcast is available on Apple Podcasts, Spotify, or wherever you get your podcasts. Please leave us a rating or review on iTunes!Comes A Time is brought to you by Osiris Media. Hosted and Produced by Oteil Burbridge and Mike Finoia. Executive Producers are Christina Collins and RJ Bee. Production, Editing and Mixing by Eric Limarenko and Matt Dwyer. Theme music by Oteil Burbridge. To discover more podcasts that connect you more deeply to the music you love, check out osirispod.com-------Visit SunsetlakeCBD.com and use the promo code TIME for 20% off premium CBD productsDiscover Garcia Hand Picked Cannabis at GarciaHandPicked.com or connect with them on Instagram at @garciahandpicked See acast.com/privacy for privacy and opt-out information.

1hr 34mins

30 Jul 2021

Episode artwork

Rick Doblin on the value of psychedelics

California Sun Podcast

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies, based in San Jose. He received his doctorate in Public Policy from Harvard’s Kennedy School, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana. Doblin has devoted his life to the development of both of the drugs and a legal framework for the beneficial uses of psychedelics in the treatment of mental illnesses, including PTSD and long-term depression. Rick is also a licensed psychedelic therapist. Ismail Ali, who joins him in this week's podcast, directs legal and legislative policy for MAPS and is the former board chairman of the Students for Sensible Drug Policy.

54mins

23 Jul 2021

Episode artwork

#202 – Rick Doblin: Psychedelics

Lex Fridman Podcast

Rick Doblin is a psychedelics researcher and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). Please support this podcast by checking out our sponsors: – Theragun: https://therabody.com/lex to get 30 day trial – ExpressVPN: https://expressvpn.com/lexpod and use code LexPod to get 3 months free – Blinkist: https://blinkist.com/lex and use code LEX to get 25% off premium – Eight Sleep: https://www.eightsleep.com/lex and use code LEX to get special savings EPISODE LINKS: Rick’s Twitter: https://twitter.com/RickDoblin MAPS: https://maps.org PODCAST INFO: Podcast website: https://lexfridman.com/podcast Apple Podcasts: https://apple.co/2lwqZIr Spotify: https://spoti.fi/2nEwCF8 RSS: https://lexfridman.com/feed/podcast/ YouTube Full Episodes: https://youtube.com/lexfridman YouTube Clips: https://youtube.com/lexclips SUPPORT

2hr 42mins

21 Jul 2021

Episode artwork

Rick Doblin: Psychedelics For Assisted Therapy

A Life of Greatness

Can psychedelics help us create a better world? Joining Sarah Grynberg in a highly thought–provoking episode is Rick Doblin, a psychedelic-assisted psychotherapist and founder of the Multidisciplinary Association for Psychedelic Studies. Together they discuss his research on the safe use of psychedelics, marijuana and prescription medicine to remedy mental health conditions that are currently without known cures. They also explore the subtleties of the drug debate, what can happen if we change our approach to the use of drugs, as well as the spiritual awareness gained from hallucinogens. This conversation will open your mind to the possibilities, solutions and change we can all create when we venture the path less-travelled. Follow Sarah for more wisdom & inspiration: Instagram: instagram.com/sarahgrynberg Website: https://sarahgrynberg.com/ Facebook: facebook.com/sarahgrynberg Twitter: twitter.com/sarahgrynberg YouTube: youtube.com/sarahgrynbergSee omnystudio.com/listener for privacy information.

1hr 2mins

7 Jun 2021

Episode artwork

Rick Doblin

Hell & High Water with John Heilemann

In which John Heilemann talks with Rick Doblin, the pioneering champion of psychedelics who has waged a decades-long crusade to bring about mainstream acceptance of psychoactive drugs for therapeutic and recreational use. Heilemann and Doblin have known each other for more than 30 years, and they discuss Doblin’s path-breaking work at the Multidisciplinary Association for Psychedelic Studies, which he founded and has turned into a multimillion dollar research and advocacy group employing 130 neuroscientists, pharmacologists, and regulatory specialists; his focus on paving the way for MDMA (aka Ecstasy or Molly) to be used in clinical settings as a treatment for depression, addiction, PTSD, and other maladies; how the cultural acceptance of marijuana (first as a medicine and then more broadly) is a leading indicator of where things are headed with MDMA, psilocybin mushrooms, LSD, and other mind-altering compounds; the future of psychedelic medicine, now that FDA approval is on the horizon; and the coming psychedelics investment bubble. Doblin also describes his personal experiences with psychedelics and how they changed his life, as well as the potential for backlash to the psychedelic renaissance, especially from fundamentalist groups, as social mores change.  See acast.com/privacy for privacy and opt-out information.

1hr 12mins

1 Jun 2021

Episode artwork

37. MAPS with Rick Doblin

The Drug Science Podcast

Richard ‘Rick’ Doblin is the founder and director of Multidisciplinary Association for Psychedelic Studies (MAPS) - a non-profit research organisation established in 1986.  Somewhere between getting an undergraduate degree in psychology and a doctorate in public policy, Rick, having had discovered psychedelics, began his fight against unjustified criminalisation of psychedelic drugs.  Rick’s main goal has been making MDMA a FDA-approved medicine, tune in to this week’s episode to find out about his progress!MAPS latest MDMA study in Nature MedicineDrug Science live podcast recording with Professor David Nutt!  Multidisciplinary Association for Psychedelic Studies (MAPS)MDMACuban Missile Crisis, Vietnam War Carl JungLSDMescalineJohn Lilly Programming & Metaprogramming in the Human Biocomputer: Theory & ExperimentsRealms of the Human Unconscious: Observations from LSD Research by Stanislav GrofIsolation tankStanislav GrofPrimal therapyNew Genesis: Shaping a global spirituality by Robert MullerLaura HuxleyIsland by Aldous HuxleyDMTPsilocybinPost-traumatic stress disorder (PTSD)AyahuascaSpinal tapDissociative identity disorder★ Support this podcast ★

51mins

26 May 2021

Loading